Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$484M |
| 2 |
Microsoft
MSFT
|
+$417M |
| 3 |
Amazon
AMZN
|
+$365M |
| 4 |
Apple
AAPL
|
+$357M |
| 5 |
Merck
MRK
|
+$311M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$420M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Philip Morris
PM
|
+$246M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$228M |
| 5 |
Meta Platforms (Facebook)
META
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Embecta
EMBC
$209M
| $31.6M | ﹤0.01% |
1,123,208
+47,211
| +4% | +$1.34M |
|
1502
RXO
RXO
$3.31B
| $31.5M | ﹤0.01% |
1,606,186
+100,859
| +7% | +$1.94M |
|
1503
Phreesia
PHR
$697M
| $31.5M | ﹤0.01% |
975,976
+43,506
| +5% | +$1.53M |
|
1504
CTS Corp
CTS
$1.89B
| $31.5M | ﹤0.01% |
635,995
+7,090
| +1% | +$317K |
|
1505
iShares MSCI Taiwan ETF
EWT
$10.6B
| – | – |
0
| – | – |
|
|
LAZR
1506
DELISTED
Luminar Technologies
LAZR
| $31.3M | ﹤0.01% |
321,863
+14,567
| +5% | +$1.53M |
|
|
CPE
1507
DELISTED
Callon Petroleum Company
CPE
| $31.3M | ﹤0.01% |
936,280
+39,777
| +4% | +$1.5M |
|
1508
Sally Beauty Holdings
SBH
$1.52B
| $31.2M | ﹤0.01% |
2,004,579
+88,691
| +5% | +$1.38M |
|
1509
Lindsay Corp
LNN
$1.16B
| $31.2M | ﹤0.01% |
206,531
+11,059
| +6% | +$1.67M |
|
1510
Trupanion
TRUP
$1.21B
| $31.2M | ﹤0.01% |
727,114
+29,451
| +4% | +$1.59M |
|
1511
Sylvamo
SLVM
$1.49B
| $31.1M | ﹤0.01% |
671,256
-8,099
| -1% | -$384K |
|
1512
TripAdvisor
TRIP
$1.2B
| $31M | ﹤0.01% |
1,560,021
+49,753
| +3% | +$1.06M |
|
1513
Brinker International
EAT
$9.83B
| $30.9M | ﹤0.01% |
813,084
+36,915
| +5% | +$1.4M |
|
1514
MillerKnoll
MLKN
$1.61B
| $30.9M | ﹤0.01% |
1,509,604
+52,834
| +4% | +$1.19M |
|
1515
QuantumScape Corp
QS
$3.41B
| $30.8M | ﹤0.01% |
3,767,420
+121,345
| +3% | +$985K |
|
1516
Hain Celestial
HAIN
$53M
| $30.8M | ﹤0.01% |
1,794,025
+66,721
| +4% | +$1.22M |
|
|
CPRX
1517
DELISTED
Catalyst Pharmaceutical
CPRX
| $30.7M | ﹤0.01% |
1,854,222
+90,832
| +5% | +$1.5M |
|
|
STR
1518
DELISTED
Sitio Royalties
STR
| $30.7M | ﹤0.01% |
1,360,147
+94,310
| +7% | +$2.34M |
|
|
CERE
1519
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $30.7M | ﹤0.01% |
1,257,920
+53,812
| +4% | +$1.58M |
|
1520
Lakeland Financial Corp
LKFN
$1.55B
| $30.7M | ﹤0.01% |
489,530
+21,703
| +5% | +$1.51M |
|
|
BWIN
1521
Baldwin Insurance Group
BWIN
$2.81B
| $30.6M | ﹤0.01% |
1,203,009
+55,488
| +5% | +$1.54M |
|
|
HTLF
1522
DELISTED
Heartland Financial USA, Inc.
HTLF
| $30.6M | ﹤0.01% |
797,022
+31,432
| +4% | +$1.44M |
|
1523
Dave & Buster's
PLAY
$348M
| $30.5M | ﹤0.01% |
829,490
+39,105
| +5% | +$1.56M |
|
1524
BioCryst Pharmaceuticals
BCRX
$2.41B
| $30.5M | ﹤0.01% |
3,653,556
+187,006
| +5% | +$1.8M |
|
1525
Stride
LRN
$3.43B
| $30.3M | ﹤0.01% |
772,571
+49,314
| +7% | +$1.94M |
|
Similar funds
Geode Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Geode Capital Management held 4,968 positions worth $770B, up 8.1% from $713B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.6%. Geode Capital Management opened 69 new positions and exited 162, leaving the 4,968-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2023 buy was GE HealthCare: 6,775,612 shares worth $554M.
- Geode Capital Management added most to Microsoft in Q1 2023, an estimated $417M increase.
- Geode Capital Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $420M.
- Geode Capital Management fully exited SVB Financial Group in Q1 2023, selling an estimated $288M.
- Geode Capital Management's ten largest holdings make up 23% of its $770B portfolio in Q1 2023.
- Geode Capital Management opened 69 new positions and closed 162 in Q1 2023.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $770B.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.